180 related articles for article (PubMed ID: 25164060)
1. Novel equation to determine the hepatic triglyceride concentration in humans by MRI: diagnosis and monitoring of NAFLD in obese patients before and after bariatric surgery.
Jiménez-Agüero R; Emparanza JI; Beguiristain A; Bujanda L; Alustiza JM; García E; Hijona E; Gallego L; Sánchez-González J; Perugorria MJ; Asensio JI; Larburu S; Garmendia M; Larzabal M; Portillo MP; Aguirre L; Banales JM
BMC Med; 2014 Aug; 12():137. PubMed ID: 25164060
[TBL] [Abstract][Full Text] [Related]
2. Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology.
Calvo N; Beltrán-Debón R; Rodríguez-Gallego E; Hernández-Aguilera A; Guirro M; Mariné-Casadó R; Millá L; Alegret JM; Sabench F; del Castillo D; Vinaixa M; Rodríguez MÀ; Correig X; García-Álvarez R; Menendez JA; Camps J; Joven J
World J Gastroenterol; 2015 Jun; 21(24):7529-44. PubMed ID: 26140000
[TBL] [Abstract][Full Text] [Related]
3. Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLD.
Permutt Z; Le TA; Peterson MR; Seki E; Brenner DA; Sirlin C; Loomba R
Aliment Pharmacol Ther; 2012 Jul; 36(1):22-9. PubMed ID: 22554256
[TBL] [Abstract][Full Text] [Related]
4. Validation of water-fat MRI and proton MRS in assessment of hepatic fat and the heterogeneous distribution of hepatic fat and iron in subjects with non-alcoholic fatty liver disease.
Hui SCN; So HK; Chan DFY; Wong SKH; Yeung DKW; Ng EKW; Chu WCW
Eur J Radiol; 2018 Oct; 107():7-13. PubMed ID: 30292275
[TBL] [Abstract][Full Text] [Related]
5. Association between novel MRI-estimated pancreatic fat and liver histology-determined steatosis and fibrosis in non-alcoholic fatty liver disease.
Patel NS; Peterson MR; Brenner DA; Heba E; Sirlin C; Loomba R
Aliment Pharmacol Ther; 2013 Mar; 37(6):630-9. PubMed ID: 23383649
[TBL] [Abstract][Full Text] [Related]
6. PERFORMACE OF TRIGLYCERIDE-GLUCOSE INDEX ON DIAGNOSIS AND STAGING OF NAFLD IN OBESE PATIENTS.
Smiderle CA; Coral GP; DE Carli LA; Mattos AA; Mattos AZ; Tovo CV
Arq Gastroenterol; 2021; 58(2):139-144. PubMed ID: 34231659
[TBL] [Abstract][Full Text] [Related]
7. Correlation between magnetic resonance imaging proton density fat fraction (MRI-PDFF) and liver biopsy to assess hepatic steatosis in obesity.
Wibulpolprasert P; Subpinyo B; Chirnaksorn S; Shantavasinkul PC; Putadechakum S; Phongkitkarun S; Sritara C; Angkathunyakul N; Sumritpradit P
Sci Rep; 2024 Mar; 14(1):6895. PubMed ID: 38519637
[TBL] [Abstract][Full Text] [Related]
8. Accuracy of multi-echo Dixon sequence in quantification of hepatic steatosis in Chinese children and adolescents.
Zhao YZ; Gan YG; Zhou JL; Liu JQ; Cao WG; Cheng SM; Bai DM; Wang MZ; Gao FQ; Zhou SM
World J Gastroenterol; 2019 Mar; 25(12):1513-1523. PubMed ID: 30948914
[TBL] [Abstract][Full Text] [Related]
9. A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease.
Idilman IS; Keskin O; Celik A; Savas B; Elhan AH; Idilman R; Karcaaltincaba M
Acta Radiol; 2016 Mar; 57(3):271-8. PubMed ID: 25855666
[TBL] [Abstract][Full Text] [Related]
10. PNPLA3 p.I148M variant is associated with greater reduction of liver fat content after bariatric surgery.
Krawczyk M; Jiménez-Agüero R; Alustiza JM; Emparanza JI; Perugorria MJ; Bujanda L; Lammert F; Banales JM
Surg Obes Relat Dis; 2016 Dec; 12(10):1838-1846. PubMed ID: 27576208
[TBL] [Abstract][Full Text] [Related]
11. Quantitative magnetic resonance imaging of hepatic steatosis: Validation in ex vivo human livers.
Bannas P; Kramer H; Hernando D; Agni R; Cunningham AM; Mandal R; Motosugi U; Sharma SD; Munoz del Rio A; Fernandez L; Reeder SB
Hepatology; 2015 Nov; 62(5):1444-55. PubMed ID: 26224591
[TBL] [Abstract][Full Text] [Related]
12. Association Between Magnetic Resonance Imaging-Proton Density Fat Fraction and Liver Histology Features in Patients With Nonalcoholic Fatty Liver Disease or Nonalcoholic Steatohepatitis.
Wildman-Tobriner B; Middleton MM; Moylan CA; Rossi S; Flores O; Chang ZA; Abdelmalek MF; Sirlin CB; Bashir MR
Gastroenterology; 2018 Nov; 155(5):1428-1435.e2. PubMed ID: 30031769
[TBL] [Abstract][Full Text] [Related]
13. Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.
Imajo K; Kessoku T; Honda Y; Tomeno W; Ogawa Y; Mawatari H; Fujita K; Yoneda M; Taguri M; Hyogo H; Sumida Y; Ono M; Eguchi Y; Inoue T; Yamanaka T; Wada K; Saito S; Nakajima A
Gastroenterology; 2016 Mar; 150(3):626-637.e7. PubMed ID: 26677985
[TBL] [Abstract][Full Text] [Related]
14. A prediction model of liver fat fraction and presence of non-alcoholic fatty liver disease (NAFLD) among patients with overweight or obesity.
Chen J; Yue J; Fu J; He S; Liu Q; Yang M; Zhang W; Xu H; Lu Q; Ma J
Endocr J; 2023 Oct; 70(10):977-985. PubMed ID: 37599066
[TBL] [Abstract][Full Text] [Related]
15. The Role of Three-Dimensional Magnetic Resonance Elastography in the Diagnosis of Nonalcoholic Steatohepatitis in Obese Patients Undergoing Bariatric Surgery.
Allen AM; Shah VH; Therneau TM; Venkatesh SK; Mounajjed T; Larson JJ; Mara KC; Schulte PJ; Kellogg TA; Kendrick ML; McKenzie TJ; Greiner SM; Li J; Glaser KJ; Wells ML; Chen J; Ehman RL; Yin M
Hepatology; 2020 Feb; 71(2):510-521. PubMed ID: 30582669
[TBL] [Abstract][Full Text] [Related]
16. The HAALT Non-invasive Scoring System for NAFLD in Obesity.
Sheth H; Bagasrawala S; Shah M; Ansari R; Olithselvan A; Lakdawala M
Obes Surg; 2019 Aug; 29(8):2562-2570. PubMed ID: 31016455
[TBL] [Abstract][Full Text] [Related]
17. Increased circulating zonulin in children with biopsy-proven nonalcoholic fatty liver disease.
Pacifico L; Bonci E; Marandola L; Romaggioli S; Bascetta S; Chiesa C
World J Gastroenterol; 2014 Dec; 20(45):17107-14. PubMed ID: 25493023
[TBL] [Abstract][Full Text] [Related]
18. SFRP5 hepatic expression is associated with non-alcoholic liver disease in morbidly obese women.
Gutiérrez-Vidal R; Vega-Badillo J; Reyes-Fermín LM; Hernández-Pérez HA; Sánchez-Muñoz F; López-Álvarez GS; Larrieta-Carrasco E; Fernández-Silva I; Méndez-Sánchez N; Tovar AR; Villamil-Ramírez H; Mejía-Domínguez AM; Villarreal-Molina T; Hernández-Pando R; Campos-Pérez F; Aguilar-Salinas CA; Canizales-Quinteros S
Ann Hepatol; 2015; 14(5):666-74. PubMed ID: 26256895
[TBL] [Abstract][Full Text] [Related]
19. Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients.
Garg H; Aggarwal S; Shalimar ; Yadav R; Datta Gupta S; Agarwal L; Agarwal S
Surg Obes Relat Dis; 2018 Jan; 14(1):81-91. PubMed ID: 29126863
[TBL] [Abstract][Full Text] [Related]
20. Quantitative MRI for hepatic fat fraction and T2* measurement in pediatric patients with non-alcoholic fatty liver disease.
Deng J; Fishbein MH; Rigsby CK; Zhang G; Schoeneman SE; Donaldson JS
Pediatr Radiol; 2014 Nov; 44(11):1379-87. PubMed ID: 24840769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
